Evidence map›Paper›PMID 28930139›Full record

ReviewMedicines (Basel, Switzerland)2016

Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.

Muhammad Shahdaat Bin Sayeed, Selim Muhammad Rezaul Karim, Tasnuva Sharmin, Mohammed Monzur Morshed

Open access · goldAbstract readReview
In one paragraph

Review in Medicines (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Plants (Basel, Switzerland) · 2025
    Review
  4. Aspects of β-sitosterol's Pharmacology, Nutrition and Analysis.Current pharmaceutical biotechnology · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  16. Article
  17. Effect ofFrontiers in physiology · 2023
    Article
  18. Novel Therapeutics for Treating Sleep Disorders: New Perspectives onInternational journal of molecular sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Muhammad Shahdaat Bin SayeedDepartment of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka-1000, Bangladesh. shahdaat2013@du.ac.bd.ORCID 0000-0003-0027-9614
Selim Muhammad Rezaul KarimDepartment of Pharmacy, Daffodil International University, Dhaka-1207, Bangladesh. smroney46@gmail.com.
Tasnuva SharminDepartment of Pharmaceutical Chemistry, University of Dhaka, Dhaka-1000, Bangladesh. tasnuva.phr.du@gmail.com.
Mohammed Monzur MorshedDepartment of Biochemistry and Molecular, Biology, University of Dhaka, Dhaka-1000, Bangladesh. monzurmorshed.du@gmail.com.
University of Dhaka · BDDaffodil International University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta-sitosterol (BS) is a phytosterol, widely distributed throughout the plant kingdom and known to be involved in the stabilization of cell membranes. To compile the sources, physical and chemical properties, spectral and chromatographic analytical methods, synthesis, systemic effects, pharmacokinetics, therapeutic potentials, toxicity, drug delivery and finally, to suggest future research with BS, classical as well as on-line literature were studied. Classical literature includes classical books on ethnomedicine and phytochemistry, and the electronic search included Pubmed, SciFinder, Scopus, the Web of Science, Google Scholar, and others. BS could be obtained from different plants, but the total biosynthetic pathway, as well as its exact physiological and structural function in plants, have not been fully understood. Different pharmacological effects have been studied, but most of the mechanisms of action have not been studied in detail. Clinical trials with BS have shown beneficial effects in different diseases, but long-term study results are not available. These have contributed to its current status as an "orphan phytosterol". Therefore, extensive research regarding its effect at cellular and molecular level in humans as well as addressing the claims made by commercial manufacturers such as the cholesterol lowering ability, immunological activity etc. are highly recommended.

Indexed as

beta-sitosterolcharacterizationdrug deliveryorphan phytosteroltherapeutic potential

Identifiers

PMID28930139
PMCPMC5456237
OpenAlexW2552642879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.